Similar articles

• A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: a Kansai Clinical Oncology Group study (KCOG0015 trial).

  Ito K, Tsubamoto H, Itani Y, Kuroboshi H, Fujita H, Nobunaga T, Coleman RL. Ito K, et al. Gynecol Oncol. 2011 Feb;120(2):193-7. doi: 10.1016/j.ygyno.2010.10.025. Epub 2010 Dec 22. Gynecol Oncol. 2011. PMID: 21075434 Clinical Trial.
• [Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].

  Nakashima R, Enomoto T, Murata Y, Fujita M. Nakashima R, et al. Nihon Rinsho. 2004 Oct;62 Suppl 10:360-4. Nihon Rinsho. 2004. PMID: 15535268 Review. Japanese. No abstract available.
• Docetaxel and carboplatin combination chemotherapy for recurrent endometrial cancer.

  Obata H, Aoki Y, Watanabe M, Matsushita H, Yahata T, Fujita K, Kurata H, Tanaka K. Obata H, et al. Int J Clin Oncol. 2003 Feb;8(1):53-5. doi: 10.1007/s101470300008. Int J Clin Oncol. 2003. PMID: 12601544
• Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.

  Lupe K, D'Souza DP, Kwon JS, Radwan JS, Harle IA, Hammond JA, Carey MS. Lupe K, et al. Gynecol Oncol. 2009 Jul;114(1):94-8. doi: 10.1016/j.ygyno.2009.03.027. Epub 2009 Apr 29. Gynecol Oncol. 2009. PMID: 19406459
• Management of advanced-stage and recurrent endometrial cancer.

  Ray M, Fleming G. Ray M, et al. Semin Oncol. 2009 Apr;36(2):145-54. doi: 10.1053/j.seminoncol.2008.12.006. Semin Oncol. 2009. PMID: 19332249 Review.